SCP
IMMP

Sender Company & Partners’s Immutep IMMP Stock Holding History

Sender Company & Partners’s Portfolio IMMP Stock Details IMMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.8K Sell
53,800
-124,400
-70% -$285K 0.01% 53
2025
Q4 		$510K Buy
178,200
+40,000
+29% +$84.2K 0.24% 58
2025
Q3 		$242K Buy
138,200
+94,800
+218% +$161K 0.03% 376
2025
Q2 		$71.2K Buy
+43,400
New +$75.6K 0.02% 266

Other funds holding IMMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sender Company & Partners's IMMP Position: Q4 2025 in Review

Sender Company & Partners sold out of Immutep (IMMP) in Q4 2025, closing a stake of 215,861 shares — an estimated $454K sold.

Sender Company & Partners first reported a position in IMMP in Q2 2025 and held it in 2 quarters. The position peaked at $378K in Q3 2025. 25 funds tracked by Wall St. Rank hold IMMP as of Q4 2025.

  • Sender Company & Partners reported no remaining Immutep position as of Q4 2025 after selling out during the quarter.
  • Sender Company & Partners sold 215,861 Immutep shares in Q4 2025, an estimated $454K.
  • Sender Company & Partners first reported a position in Immutep in Q2 2025 and held it in 2 quarters.
  • Sender Company & Partners's Immutep position peaked at $378K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held Immutep as of Q4 2025.

Based on Sender Company & Partners's 13F filing for Q4 2025, filed 17 Feb 2026.